Filer Snapshot

Vicapsys Life Sciences, Inc. SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001468639.

Entity Type

Company

Total Filings

92

Latest Filing

27 Mar 2025

Industry

Pharmaceutical Preparations

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Source: SEC filing 15-12G

15-12G filed on 27 Mar 2025 for CIK 0001468639.

View Source Filing
Symbol
VICP on OTC
Business address
1735 Buford Highway, Ste. 215 113, Cumming, GA, 30041
State of incorporation
FL
Fiscal year end
31 December
Former names
SSGI, INC. (to 07 Nov 2016)

Quick Takeaways

  • Vicapsys Life Sciences, Inc. is an SEC filer tracked under CIK 0001468639.
  • 92 filings are listed on this profile.
  • Common form coverage includes 15-12G, SCHEDULE 13G, 3 and more.

What Changed

  • Latest filing: 15-12G filed on 27 Mar 2025.
  • Report period: not specified in filing header.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC filing 15-12G

15-12G filed on 27 Mar 2025 for CIK 0001468639.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed 15-12G can change the filing history, ownership context, or next research path for Vicapsys Life Sciences, Inc..

Latest source-backed update
15-12G filed 27 Mar 2025
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: 15-12G filed 27 Mar 2025.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Latest update

What changed recently for Vicapsys Life Sciences, Inc.

New fact period available

Latest financial period: Q3 2024. Open the source-backed page to inspect the fresh filing or facts context.

Update date

10 Jan 2025

Page type

Company facts

Latest period

Q3 2024

SEC-backed company facts were refreshed from filings filed on 10 Jan 2025.

Benchmark Context

Benchmark context for this company

Vicapsys Life Sciences, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q3 2024. That gives you a fresh baseline before you compare this company with peers.

  • Latest company facts filing date: 10 Jan 2025.
  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Company intelligence

Research Vicapsys Life Sciences, Inc. from filings to ownership signals

Use this company page as the hub for SEC filings, fundamentals, insider activity, large-stake holders, and institutional ownership context.

Active modules

3/5

Available company intelligence paths on this page.

Filings

92

SEC submissions provide the evidence trail.

Ownership context

1/3

Insider, large-stake, and institutional ownership lanes.

Return loop

Watch

Save the company so the next source-backed change has a clear place to bring you back.

Best-of company intelligence workflow

What changed?

Start with the latest filing and active ownership modules before opening older table rows.

Why might it matter?

Use insider, 13D/G, and 13F context to separate routine filings from ownership signals.

Where is evidence?

Keep SEC source documents one click away through filings, facts, insider reports, and Schedule 13D/G records.

What to watch next?

Save the company so watchlists can bring you back when the next filing-backed update lands.

SEC-verifiable company research path

Every company hub should answer what changed, why ownership activity might matter, where SEC evidence lives, and which filer, insider, holder, or filing page deserves the next click.

SEC filings

Available

Latest company filings

Start with the filing timeline to verify the newest source document and report period.

Open filings table

Company facts

Available

Financial context

Use XBRL facts when ownership activity needs revenue, earnings, debt, or cash-flow context.

Open company facts

Forms 3/4/5

Available

Insider activity

Check whether directors, officers, or 10% owners are buying, selling, or filing fresh ownership changes.

Open insider activity

Schedule 13D/G

Explore

Large-stake holders

Review beneficial ownership filings for activist-style or passive large holder changes around this issuer.

Browse large-stake radar

Form 13F

Explore

Institutional holders

Compare manager filings and smart-money context when company-level ownership needs broader holders.

Browse smart-money dashboard

SEC-verifiable company hub

The strongest research path is the one that keeps source documents close: filings first, then ownership signals, insider context, and fundamentals.

Create free account to watch this company

Watchlist return triggers

Watch Vicapsys Life Sciences, Inc. when any filing-backed ownership signal appears, then jump back into the exact SEC evidence path.

new company filing insider Form 4 13D/G holder change 13F holder update

Filer Overview

Vicapsys Life Sciences, Inc. has filed 92 SEC EDGAR filings since 17 Jul 2009. Common forms include 15-12G, SCHEDULE 13G, 3, 10-Q and more.

Latest Filings

Recent SEC filings for Vicapsys Life Sciences, Inc. with direct links to document and filing folders.

15-12G File 000-56145

15-12G filing

Filing date
27 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-85123

SCHEDULE 13G filing

Filing date
21 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
21 Mar 2025
Reporting date
20 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
10 Jan 2025
Reporting date
30 Sep 2024
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
10 Jan 2025
Reporting date
30 Jun 2024
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
10 Jan 2025
Reporting date
31 Mar 2024
Next action
Verify source filing
10-K File 000-56145

10-K filing

Filing date
21 Oct 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
SEC STAFF ACTION

SEC STAFF ACTION filing

Filing date
27 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
14 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
14 Aug 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
DEF 14C File 000-56145

DEF 14C filing

Filing date
09 Aug 2023
Reporting date
09 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 000-56145

PRE 14C filing

Filing date
28 Jul 2023
Reporting date
28 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-486774

D filing

Filing date
13 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-56145

8-K/A filing

Filing date
18 May 2023
Reporting date
12 May 2023
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
15 May 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
10-K File 000-56145

10-K filing

Filing date
14 Apr 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
NT 10-K File 000-56145

NT 10-K filing

Filing date
31 Mar 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-56145

DEF 14C filing

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
21 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
NT 10-Q File 000-56145

NT 10-Q filing

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
16 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
NT 10-Q File 000-56145

NT 10-Q filing

Filing date
15 Aug 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-56145

DEF 14C filing

Filing date
17 May 2022
Reporting date
17 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
13 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
PRE 14C File 000-56145

PRE 14C filing

Filing date
06 May 2022
Reporting date
06 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-56145

10-K filing

Filing date
16 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
12 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
20 Sep 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
20 Sep 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
10-K File 000-56145

10-K filing

Filing date
17 Sep 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
13 Sep 2021
Reporting date
30 Sep 2020
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
09 Sep 2021
Reporting date
30 Jun 2020
Next action
Verify source filing
10-Q File 000-56145

10-Q filing

Filing date
15 May 2020
Reporting date
31 Mar 2020
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
06 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-12G/A File 000-56145

10-12G/A filing

Filing date
30 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
27 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
20 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-12G/A File 000-56145

10-12G/A filing

Filing date
20 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
11 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-12G File 000-56145

10-12G filing

Filing date
12 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-305893

D filing

Filing date
16 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-302620

D filing

Filing date
08 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
15-15D File 333-160700

15-15D filing

Filing date
07 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Sep 2010
Reporting date
03 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-160700

10-Q filing

Filing date
24 Aug 2010
Reporting date
30 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 333-160700

NT 10-Q filing

Filing date
16 Aug 2010
Reporting date
30 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Aug 2010
Reporting date
09 Aug 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 333-160700

8-K/A filing

Filing date
29 Jul 2010
Reporting date
13 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-160700

8-K filing

Filing date
01 Jul 2010
Reporting date
30 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-160700

10-Q filing

Filing date
22 Jun 2010
Reporting date
31 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-142513

D filing

Filing date
25 May 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 333-160700

10-K filing

Filing date
24 May 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-142456

D filing

Filing date
24 May 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85123

SC 13G filing

Filing date
20 May 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
20 May 2010
Reporting date
13 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-160700

8-K filing

Filing date
18 May 2010
Reporting date
13 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 333-160700

NT 10-Q filing

Filing date
17 May 2010
Reporting date
31 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-160700

8-K filing

Filing date
26 Apr 2010
Reporting date
20 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-160700

8-K filing

Filing date
12 Apr 2010
Reporting date
08 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K/A File 333-160700

NT 10-K/A filing

Filing date
02 Apr 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 333-160700

NT 10-K filing

Filing date
01 Apr 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
29 Jan 2010
Reporting date
26 Jan 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jan 2010
Reporting date
17 Jan 2010
SEC evidence
Open document Open filing
Next action
Verify source filing

About this filer

Vicapsys Life Sciences, Inc. files with the SEC under CIK 0001468639. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .